BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25237623)

  • 1. An overview of translational (radio)pharmaceutical research related to certain oncological and non-oncological applications.
    Cona MM; de Witte P; Verbruggen A; Ni Y
    World J Methodol; 2013 Dec; 3(4):45-64. PubMed ID: 25237623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of iodine-123-labeled hypericin and (99m)Tc-labeled hexakis [2-methoxy isobutyl isonitrile] in a rabbit model of myocardial infarction.
    Cona MM; Feng Y; Li Y; Chen F; Vunckx K; Zhou L; Van Slambrouck K; Rezaei A; Gheysens O; Nuyts J; Verbruggen A; Oyen R; Ni Y
    J Cardiovasc Pharmacol; 2013 Sep; 62(3):304-11. PubMed ID: 23714775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Preclinical Evaluation of Radioiodinated Hypericin Dicarboxylic Acid as a Necrosis Avid Agent in Rat Models of Induced Hepatic, Muscular, and Myocardial Necroses.
    Li J; Zhang J; Yang S; Jiang C; Zhang D; Jin Q; Wang Q; Wang C; Ni Y; Yin Z; Song S
    Mol Pharm; 2016 Jan; 13(1):232-40. PubMed ID: 26568406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radioiodinated hypericin: its biodistribution, necrosis avidity and therapeutic efficacy are influenced by formulation.
    Cona MM; Alpizar YA; Li J; Bauwens M; Feng Y; Sun Z; Zhang J; Chen F; Talavera K; de Witte P; Verbruggen A; Oyen R; Ni Y
    Pharm Res; 2014 Feb; 31(2):278-90. PubMed ID: 23934256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sodium cholate, a solubilizing agent for the necrosis avid radioiodinated hypericin in rabbits with acute myocardial infarction.
    Cona MM; Feng Y; Zhang J; Li Y; Verbruggen A; Oyen R; Ni Y
    Drug Deliv; 2015 May; 22(3):427-35. PubMed ID: 24417698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential Administrations of a Vascular-Disrupting Agent, High-Intensity Focused Ultrasound, and a Radioactively labeled Necrosis Avid Compound for Eradicating Solid Malignancies.
    Li Y; Wang S; Chen L; Feng Y; Shen Z; Chen X; Huang G; Ni Y
    Technol Cancer Res Treat; 2022; 21():15330338221136716. PubMed ID: 36344243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targetability and biodistribution of radioiodinated hypericin: comparison between microdosing and carrier-added preparations.
    Cona MM; Li J; Feng Y; Chen F; Verbruggen A; Witte Pd; Oyen R; Ni Y
    Anticancer Agents Med Chem; 2014; 14(6):852-61. PubMed ID: 24102315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and validation of cyclodextrin-based excipients for radioiodinated hypericin applied in a targeted cancer radiotherapy.
    Li Y; Wang S; Jiang X; Wang X; Zhou X; Wan L; Zhao H; Zhou Z; Gao L; Huang G; Ni Y; He X
    Int J Pharm; 2021 Apr; 599():120393. PubMed ID: 33639227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantification of acute reperfused myocardial infarction in rabbits using DISA-SPECT/CT and 3.0T cardiac MRI.
    Feng Y; Cona MM; Vunckx K; Li Y; Chen F; Nuyts J; Gheysens O; Zhou L; Xie Y; Oyen R; Ni Y
    Int J Cardiol; 2013 Oct; 168(4):4191-8. PubMed ID: 23932045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Molecule Sequential Dual-Targeting Theragnostic Strategy (SMSDTTS): from Preclinical Experiments towards Possible Clinical Anticancer Applications.
    Li J; Oyen R; Verbruggen A; Ni Y
    J Cancer; 2013; 4(2):133-45. PubMed ID: 23412554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Model In Vitro Study Using Hypericin: Tumor-Versus Necrosis-Targeting Property and Possible Mechanisms.
    Li Y; Wang S; Zhao Y; Saiyin H; He X; Zhao J; Li L; Talebi A; Huang G; Ni Y
    Biology (Basel); 2020 Jan; 9(1):. PubMed ID: 31936002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biodistribution and radiation dosimetry of radioiodinated hypericin as a cancer therapeutic.
    Cona MM; Koole M; Feng Y; Liu Y; Verbruggen A; Oyen R; Ni Y
    Int J Oncol; 2014 Mar; 44(3):819-29. PubMed ID: 24366374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necrosis avidity: a newly discovered feature of hypericin and its preclinical applications in necrosis imaging.
    Jiang B; Wang J; Ni Y; Chen F
    Theranostics; 2013; 3(9):667-76. PubMed ID: 24052807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring theranostic potentials of radioiodinated hypericin in rodent necrosis models.
    Li J; Cona MM; Chen F; Feng Y; Zhou L; Yu J; Nuyts J; de Witte P; Zhang J; Himmelreich U; Verbruggen A; Ni Y
    Theranostics; 2012; 2(10):1010-9. PubMed ID: 23139728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of skeleton structure on necrosis targeting and clearance properties of radioiodinated dianthrones.
    Zhang D; Jiang C; Yang S; Gao M; Huang D; Wang X; Shao H; Feng Y; Sun Z; Ni Y; Zhang J; Yin Z
    J Drug Target; 2016; 24(6):566-77. PubMed ID: 26586010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodinated hypericin disulfonic acid sodium salts as a DNA-binding probe for early imaging of necrotic myocardium.
    Duan X; Yin Z; Jiang C; Jin Q; Zhang D; Sun Z; Ye W; Zhang J
    Eur J Pharm Biopharm; 2017 Aug; 117():151-159. PubMed ID: 28414189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Evaluation of Radioiodinated Flavonoids as Necrosis-Avid Agents and Application in Early Assessment of Tumor Necrosis.
    Liang J; Sun Z; Zhang D; Jin Q; Cai L; Ma L; Liu W; Ni Y; Zhang J; Yin Z
    Mol Pharm; 2018 Jan; 15(1):207-215. PubMed ID: 29226682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of solubility and targetability of radioiodinated hypericin by using sodium cholate based solvent in rat models of necrosis.
    Ji Y; Zhan Y; Jiang C; Jiang X; Gao M; Liu W; Li Y; Wang J; Wang Q; Cona MM; Yao N; Wang X; Fang Z; Yin Z; Zhang J; Sun Z; Ni Y
    J Drug Target; 2014 May; 22(4):304-12. PubMed ID: 24328682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Necrosis affinity evaluation of 131I-hypericin in a rat model of induced necrosis.
    Kong M; Zhang J; Jiang C; Jiang X; Li Y; Gao M; Yao N; Huang D; Wang X; Fang Z; Liu W; Sun Z; Ni Y
    J Drug Target; 2013 Jul; 21(6):604-10. PubMed ID: 23627568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of Necrosis Avidity and Potential for Rapid Imaging of Necrotic Myocardium of Radioiodinated Hypocrellins.
    Jin Q; Zhao J; Gao M; Feng Y; Liu W; Yin Z; Li T; Song S; Ni Y; Zhang J; Huang D; Zhang D
    Mol Imaging Biol; 2018 Aug; 20(4):551-561. PubMed ID: 29305726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.